Jet Lag Relief

Anamirta Cocculus Seed, Arnica Montana, Strychnos Nux-vomica Whole


Laboratoires Boiron
Human Otc Drug
NDC 0220-9214
Jet Lag Relief also known as Anamirta Cocculus Seed, Arnica Montana, Strychnos Nux-vomica Whole is a human otc drug labeled by 'Laboratoires Boiron'. National Drug Code (NDC) number for Jet Lag Relief is 0220-9214. This drug is available in dosage form of Pellet. The names of the active, medicinal ingredients in Jet Lag Relief drug includes Anamirta Cocculus Seed - 6 [hp_C]/1 Arnica Montana - 6 [hp_C]/1 Strychnos Nux-vomica Whole - 30 [hp_C]/1 . The currest status of Jet Lag Relief drug is Active.

Drug Information:

Drug NDC: 0220-9214
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Jet Lag Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Anamirta Cocculus Seed, Arnica Montana, Strychnos Nux-vomica Whole
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Laboratoires Boiron
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Pellet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ANAMIRTA COCCULUS SEED - 6 [hp_C]/1
ARNICA MONTANA - 6 [hp_C]/1
STRYCHNOS NUX-VOMICA WHOLE - 30 [hp_C]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Jan, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 12 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Laboratoires Boiron
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0000700000218
0306969214435
UPC stands for Universal Product Code.
UNII:810258W28U
O80TY208ZW
AB2NX17POS
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0220-9214-433 TUBE in 1 PACKAGE (0220-9214-43) / 80 PELLET in 1 TUBE01 Jan, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose* cocculus indicus 6c hpus (0.443 mg) ..... relieves nausea associated with jet lag arnica montana 6c hpus (0.443 mg) ..... relieves muscle pain and stiffness nux vomica 30c hpus (0.443 mg) ..... relieves drowsiness and digestive problems associated with travel

Product Elements:

Jet lag relief anamirta cocculus seed, arnica montana, strychnos nux-vomica whole sucrose lactose anamirta cocculus seed anamirta cocculus seed arnica montana arnica montana strychnos nux-vomica whole strychnos nux-vomica whole

Indications and Usage:

Uses* temporarily relieves symptoms such as: nausea stiffness muscle pain drowsiness

Warnings:

Stop use and ask a doctor if symptoms persist for more than 3 days or worsen, new symptoms occur, or if redness or swelling if present. these could be signs of a serious condition. if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions keep packaging to save these directions for use. adults and children 2 years of age and older: dissolve 5 pellets of each medicine under the tongue: the day before traveling. just before travel. at the onset of symptoms, then repeat 3 times a day until symptoms are relieved or as directed by a doctor. children under 2 years of age: ask a doctor.

Stop Use:

Stop use and ask a doctor if symptoms persist for more than 3 days or worsen, new symptoms occur, or if redness or swelling if present. these could be signs of a serious condition.

Package Label Principal Display Panel:

Principle display panel - jet lag relief label 07.2019 image

Further Questions:

Questions, comments? questions or comments? boironusa.com info@boiron.com 1-800-boiron-1 (1-800-264-7661) distributed by boiron inc. newtown square, pa 19073-3267


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.